Work

Imatinib mesylate lacks efficacy in relapsed/refractory peripheral T cell lymphoma

Year: 2014

Type: article

Study design: Clinical Trial

Source: Leukemia & lymphoma/Leukemia and lymphoma

DOI: 10.3109/10428194.2014.941835

Authors: Eric Jacobsen, Olga Pozdnyakova, Robert Redd, David C. Fisher, David M. Dorfman, Paola Dal Cin, Ann LaCasce, Philippe Armand, Ephraim Hochberg, Gregory Cote, Ali Shahsafaei, Donna Neuberg, Jennifer R. Brown, Arnold S. Freedman

Institutions: Dana-Farber Cancer Institute, Brigham and Women's Hospital, Massachusetts General Hospital

Language: English

Topic: Lymphoma Diagnosis and Treatment

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2008431970

FWCI:

Cites: 13

Cited by: 3

Related to: 10